medline.ch Onkologie Urologische Tumoren

	Bladder-preserving trimodality therapy for muscle-invasive bladder cancer: current state of the art. Expert Rev Anticancer Ther Fahey C, Sud S, Remella A, Milowsky M. PMID: 42139181 [PubMed - as supplied by publisher]
	A Rare Case of Primary Pulmonary Choriocarcinoma Metastasizing to the Kidney: Diagnostic and Therapeutic Complexities. Cancer Rep (Hoboken) Belics Z, Fürich A, Bogyó L, Tihanyi H, Madarász M, Rózsa D, Molnár G, Gérecz B, Hupuczi P. PMID: 42138484 [PubMed - indexed for MEDLINE]
	Preliminary results and experiences of fluorescence confocal microscopy using the HistologÂ® Scanner in prostate cancer diagnostics: a feasibility study. BJU Int Meszes-Tóth A, Gyulai AT, Izsák B, Erdélyi AE, Gáti Z, Schönleber J, Tenke P, Köves B. PMID: 42138307 [PubMed - as supplied by publisher]
	Metastatic tropism of molecularly defined clear-cell renal cell carcinoma clusters. J Clin Invest Haddad G, Guo J, Xi Y, Albayrak E, Huseni M, Hamidi H, Banchereau R, Kadel E, Dubey S, Carter C, Kapur P, Brugarolas J, Pedrosa I. PMID: 42138077 [PubMed - indexed for MEDLINE]
	Cardiometabolic comorbidities and prostate cancer risk: evidence from the prostate, lung, colorectal, and ovarian cancer screening trial. Front Oncol Zhu Q, Zeng L, Chen M. PMID: 42137169 [PubMed]
	Urine-based PSMA detection for noninvasive prostate cancer diagnosis: recent advances, translational challenges, and future perspectives. Front Oncol Jiao Z, Deng C, Hu J, Zhu S. PMID: 42137166 [PubMed]
	Distinct protein and metabolic profiles in patients with advanced clear-cell renal cell carcinoma treated with sunitinib: a study of the Spanish oncology genitourinary group. Front Oncol Quintás G, Sanmartín E, Garcia-Gimenez A, Muñoz-Langa J, Collado A, Suárez C, García Del Muro X, Méndez-Vidal MJ, García-Sánchez J, Salvador-Coloma C, Laínez N, Gallardo E, Munárriz J, Vázquez S, Molins C, Font de Mora J, Reynés G. PMID: 42137158 [PubMed]
	Diagnostic utility of Ki-67 proliferation index, PSA, and other immunohistochemical markers in prostatic basal cell carcinoma: A review of 24 cases in the current literature and discussion on current treatment and diagnostics. Rare Tumors DeBinya L, Mathesh V, Wang J. PMID: 42136983 [PubMed]
	The evolving role of PSA in prostate cancer screening: revisiting the evidence in the era of personalized medicine. Adv Lab Med Filella X. PMID: 42136976 [PubMed]
	Disitamab vedotin (RC48) combined with PD-1 inhibitors in locally advanced or metastatic urothelial carcinoma: clinical outcomes and prognostic factors from a multicenter real-world study. Front Immunol Zou XC, Xu LY, Yuan YY, Zhang GY, Huang JB, Zeng T. PMID: 42136642 [PubMed - indexed for MEDLINE]
	MRI Diagnosis of Giant Renal Hamartoma With Renal Venous Tumor Thrombus: Report of One Case and Literature Review. Zhongguo Yi Xue Ke Xue Yuan Xue Bao Cen WH, Shen J, Xia SS, Li YK, Yang H, Ban Y. PMID: 42136348 [PubMed - indexed for MEDLINE]
	Impact of Hormonal and Radiation Therapy on Bladder Outlet Obstruction in High-Risk Localized Prostate Cancer: A Prospective Pressure-Flow Study. Int J Urol Kyoda Y, Hori M, Nakanishi M, Shindo T, Hashimoto K, Kobayashi K, Tanaka T, Masumori N. PMID: 42136062 [PubMed - indexed for MEDLINE]
	Letter to the Editor: Advanced and Metastatic Prostate Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment, and Follow-up. Eur Urol De Laere B, Mortezavi A, Eklund M, Grönberg H, ProBio Investigators. PMID: 42135176 [PubMed - as supplied by publisher]
	Comparative and Critical Analysis of Immune-based Combinations for First-line Treatment of Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer Meirson T, Mutti L, Goldstein DA, Barkan T, Mutai R, Markel G, Goldman A, Cosmai L, Rizzo M, Porta C. PMID: 42135107 [PubMed - as supplied by publisher]
	Osteoporosis knowledge, health beliefs, and self-efficacy in UK men with prostate cancer: a cross-sectional primary care survey. Br J Gen Pract Huang Q, Oliver P, Evans J, Brown J, Mitchell C. PMID: 42134941 [PubMed - indexed for MEDLINE]
	Prostate-specific antigen (PSA) test for prostate cancer screening. Cochrane Database Syst Rev Franco JV, Hwang EC, Jung JH, Vaimberg O, Ilic D, Cleves A, Dahm P. PMID: 42134821 [PubMed - indexed for MEDLINE]
	Pelvic nodes ultra-hypo fractionated versus conventionally fractionated IMRT with HDR brachytherapy in prostate cancer: interim analysis of a collaborative multi-institutional non-inferiority phase 3 trial (PCS-XI, NCT05820633). Radiother Oncol Fabi F, Crook J, Jolicoeur M, Rauth S, Koll W, Tisseveransinghe S, Ebacher A, Niazi T, Duplan D, Bernard AA, Vavassis P, Foster W, Vigneault É, Archambault L, Beaulieu L, Lavallée MC, Lacroix F, Carignan D, Martin AG. PMID: 42134662 [PubMed - as supplied by publisher]
	NCCN GuidelinesÂ® Insights: Prostate Cancer, Version 5.2026. J Natl Compr Canc Netw Spratt DE, Srinivas S, Adra N, Ahmed B, An Y, Bitting R, Chapin B, Cheng HH, Cho SY, D'Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Gupta S, Ippolito JE, Karnes RJ, Kishan AU, Kuettel MR, Lang JM, Lee D, Lotan T, McDonald A, Morgan TM, Pessoa R, Rais-Bahrami S, Roach M 3rd, Robin T, Rosenfeld S, Scarpato KR, Seibert T, Shabsigh A, Szmulewitz R, Teply BA, Tward J, Valicenti R, VanderWeele D, Wong JK, Kovach E, Freedman-Cass D. PMID: 42134408 [PubMed - indexed for MEDLINE]
	Perioperative Systemic Treatment Options for Muscle-Invasive Bladder Cancer. J Natl Compr Canc Netw Brown JR, Parikh M. PMID: 42134402 [PubMed - indexed for MEDLINE]
	How to Optimize Treatment for Patients With Poor-Risk Testicular Cancer. Am Soc Clin Oncol Educ Book Richardson N, Tewari AK, Giannatempo P, Basin MF, Nuzzo A, Mascaro F, Feldman DR, Adra N, Daneshmand S. PMID: 42133890 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 178260

Seite 1 von 8913

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung